Previous Article | Next Article 
Journal of Clinical Microbiology, December 1998, p. 3549-3551, Vol. 36, No. 12
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Evaluation of the Abbott LCx Assay for Detection
of Neisseria gonorrhoeae in Endocervical Swab
Specimens from Females
Sue C.
Kehl,1,*
Kristina
Georgakas,2
Geoffrey R.
Swain,3,4
Gerald
Sedmak,4
Stephen
Gradus,4
Ajaib
Singh,4 and
Seth
Foldy3,4
Departments of
Pathology1 and
Family and Community
Medicine,3
Medical College of
Wisconsin, United/Dynacare Laboratories,2
and
City of Milwaukee Health
Department,4 Milwaukee, Wisconsin
Received 20 April 1998/Returned for modification 23 July
1998/Accepted 15 September 1998
 |
ABSTRACT |
The Abbott LCx Neisseria gonorrhoeae assay (Abbott
Laboratories, Abbott Park, Ill.) uses a ligase chain reaction (LCR)
amplification in the LCx probe system for detection of a specific
nucleotide sequence in the Opa-encoding gene of N. gonorrhoeae. We evaluated the LCx assay in a comparison with
conventional culture employing modified Thayer-Martin media for the
detection of N. gonorrhoeae from female endocervical
specimens obtained from patients attending a sexually transmitted
disease clinic. Discordantly LCR-positive and culture-negative
specimens were further evaluated by testing with another LCR assay
which used an N. gonorrhoeae-specific pilin probe.
Specimens positive by both LCR assays were considered confirmed LCx-positive specimens. A specimen was considered to contain N. gonorrhoeae when it was either culture positive or culture
negative and confirmed LCx positive. A total of 403 female endocervical specimens were evaluated. The prevalence of N. gonorrhoeae in this population was 8.7%. The sensitivity and
specificity of the LCx assay were 94.3 and 99.4%, and those of culture
were 77.1 and 100%, respectively. The Abbott LCx assay is a rapid,
sensitive method for detection of N. gonorrhoeae in female
endocervical specimens.
 |
INTRODUCTION |
Traditionally, culture of female
endocervical specimens using various types of modified Thayer-Martin
media has been the standard for diagnosis of females infected with
Neisseria gonorrhoeae. Nonculture methods, such as enzyme
immunoassays and DNA probes, have become available in recent years. The
advantages to nonculture methods include rapid turnaround time,
batching of tests, and the ability to detect nonviable N. gonorrhoeae. The enzyme immunoassay methods have reported
sensitivities ranging from 60.8% (12) to 92.4%
(5) when tested on female endocervical specimens and 62.5%
(11) when tested on female urine specimens. The DNA probe assay has a reported sensitivity ranging from 96.3% (7) to 100% (10) and a specificity of greater than 99% (6,
7, 10, 13). In several studies comparing culture to DNA probe assays, reported culture sensitivities have ranged from 88.9% (7) to 90.6% (10). This suggests that molecular
methods may be an improvement over traditional culture.
The Abbott LCx assay is a nonculture method which employs ligase chain
reaction (LCR) amplification in the LCx probe system for detection of
N. gonorrhoeae. We compared traditional culture of
female endocervical specimens to the LCx assay to determine if the LCx
assay is an acceptable alternative to culture.
(This study was presented in part at the 98th General Meeting of the
American Society for Microbiology [7a].)
 |
MATERIALS AND METHODS |
Specimens.
Specimens were obtained from 408 females
attending the City of Milwaukee Health Department's sexually
transmitted disease clinic. The study protocol was approved by the
Medical College of Wisconsin Human Research Review Committee, and
informed consent was obtained prior to specimen collection. The LCx
Uriprobe Swab Specimen Collection and Transport Kit (Abbott
Laboratories, Abbott Park, Ill.) was used to collect endocervical
specimens from 408 consecutive women seen at the clinic. The
large-tipped cleaning swab was used to remove excess cervical mucus.
The small-tipped swab was inserted into the endocervix and rotated for
15 to 30 s. This swab was inserted into the transport tube. A
second swab was also inserted into the endocervix and rotated for 15 to
30 s. This swab was used to inoculate a modified Thayer-Martin
agar plate at the bedside. The order of swab collection was varied so
as not to introduce bias into the data. The LCx transport tubes were
stored at 2 to 8°C for up to 4 days or at
20°C until testing was performed.
Culture.
Inoculated modified-Thayer-Martin agar plates
(DIMed, St. Paul, Minn.) were incubated at 35 ± 2°C in 5%
CO2 for up to 72 h. Quality control of the media was
performed in accordance with National Committee for Clinical Laboratory
Standards document M22-A2 (9). Cultures were examined daily.
Oxidase-positive, gram-negative diplococci were identified as
presumptive N. gonorrhoeae. Organisms were definitively
identified based on the ability to utilize carbohydrates in Cysteine
Trypticase Agar medium (Becton Dickinson, Cockeysville, Md.). Organisms
consistent with N. gonorrhoeae but not identified as such by
biochemical testing were resolved by using a monoclonal antibody
coagglutination test (GonoGen; Becton Dickinson).
LCx assay.
The LCx assay was performed in accordance with
the manufacturer's recommendations. Processed specimens were amplified
by using the LCx Thermal Cycler. Amplified products were detected by
using the LCx Analyzer. A positive control of N. gonorrhoeae
(ATCC 27631) prepared by following the manufacturer's recommendations
was included in each run to monitor the entire assay procedure,
including specimen processing. Negative controls and calibrators were
run in duplicate and included with each run as provided by the
manufacturer. A ratio of the sample rate (S) to the cutoff value (CO)
was calculated. Specimens were considered positive when the S/CO ratio
was
1.20. Specimens with S/CO ratios between 0.80 and 1.20 were
considered equivocal and retested. If the repeat test ratio was less
than 1.00, the test was considered negative.
Analysis of discordant specimens.
Specimens which were
culture negative and LCx positive or culture positive and LCx negative
were frozen at
20°C. These specimens were then tested at Abbott
Laboratories by using a second LCR assay which employed the pilin probe
set. This pilin probe set is specific for N. gonorrhoeae (2).
Statistical methods.
Sensitivity and specificity
calculations were performed by standard methods (8). The
McNemar test was used to determine the difference between the two
methods when matched specimens were used (1a).
 |
RESULTS |
Of the specimens collected from 408 women seen at the Milwaukee
Health Department, the cultures of four patients were not inoculated
and the incorrect LCx swab was submitted for one patient. A total of
403 endocervical specimens were tested by both the LCx assay and
culture. Of those, 365 were negative for N. gonorrhoeae by
both the LCx assay and culture. Twenty-five specimens (6.2%) were
positive for N. gonorrhoeae by both the LCx assay and
culture. Two specimens were equivocal on initial LCx testing. One of
the specimens was determined to be negative on repeat testing, and this
correlated with the culture results. The second specimen was also
determined to be negative on repeat testing; however, this did not
correlate with the positive culture. After repeat testing of these
equivocal specimens, there were a total of 13 specimens whose LCx
results did not correlate with the culture results. These discordant
specimens were retested by using the pilin LCR assay. Two of these were
LCx negative, culture positive, and negative by the pilin assay. Eleven
were LCx positive and culture negative; of these, three were negative
and eight were positive by the pilin assay (Table
1). There was no association between swab
collection order and results. After resolution of the discrepant
results, the sensitivity and specificity of the LCx assay based upon
the initial LCx assay result were 94.3 and 99.4%, respectively. The
sensitivity and specificity of culture were 77.1 and 100%,
respectively.
 |
DISCUSSION |
There were two LCx-negative, culture-positive specimens. One
specimen was equivocal on initial testing (S/CO = 0.98), negative on repeat testing (S/CO = 0.13), and pilin LCR assay negative. This was considered a false-negative LCx assay result. The specimen was
not tested to determine if this could be due to the presence of an
inhibitor. However, in other studies in which specimens were diluted
and retested, these specimens did become positive (4),
suggesting that an inhibitor was present. A second specimen was also
culture positive yet negative by the LCx and pilin assays. The positive
culture report had been based on Gram staining and oxidase production
of a colony on modified Thayer-Martin medium. No organism could be
propagated for definitive identification. The organism may not have
been a Neisseria species, it may have been a
Neisseria species other than N. gonorrhoeae, or
it may have been rendered nonviable by the oxidase reagent. Despite
this, the specimen was considered falsely negative by the LCx assay.
There were 11 specimens which were LCx positive and culture negative.
Eight of these specimens were confirmed as positive by the pilin assay,
while the results for three of these specimens were not confirmed.
Therefore, eight specimens were considered falsely negative by culture.
Reasons for false-negative cultures could include prior antimicrobial
therapy, loss of viability of the organisms due to transport, sampling
error, or selective inhibition due to vancomycin in the media. Only one
of these eight patients reported antibiotic use in the weeks previous
to testing. That patient had been on penicillin for 2 weeks. In that
patient, the positive LCR could have been due to detection of nonviable
organisms. The media were plated at bedside and immediately incubated,
thus effectively eliminating any loss of viability due to transport. It
is unlikely that the low sensitivity of culture is related to sampling
error, as there was no significant difference in the recovery of
N. gonorrhoeae from specimens collected before versus those
collected after the LCR swab. The media employed did contain vancomycin
so that vancomycin-susceptible N. gonorrhoeae would not have
been detected. However, when both vancomycin-containing media and media
without vancomycin have been employed in our setting, no
vancomycin-susceptible N. gonorrhoeae has been detected.
Three specimens were considered falsely positive by the LCx assay.
There can be significant psychological and social impact from
false-positive N. gonorrhoeae reports. For this reason, we examined the false-positive results more closely. According to the
manufacturer, specimens with S/CO ratios of 0.8 to 1.2, which fall
within the equivocal zone, should be retested. If the retest S/CO ratio
is >1, the specimen is considered positive. All of the specimens which
fell within the equivocal zone were negative upon repeat testing.
However, all three of the false-positive specimens fell above the gray
zone. One specimen had an S/CO ratio of 1.31, and a second specimen had
an S/CO ratio of 1.26. According to the package insert, these should be
considered positive results. Repeat testing, the pilin assay, and
culture confirmed that both of these specimens were, in fact, negative.
The third specimen had an original S/CO ratio of 4.02 and an S/CO ratio
of 3.06 on repeat testing. The pilin assay was negative. The pilin
assay is not as sensitive as the LCx assay (1) and thus may
not have been able to detect low numbers of organisms if they were
present. Alternatively, the LCx assay result may have been falsely
positive or the pilin assay result may have been falsely negative due
to some interfering substance. If the specimen was positive because of
contamination during specimen processing, the pilin assay would have
been expected to be positive also. Negative controls included in each
assay or testing of laboratory surfaces and equipment performed
routinely to monitor for contamination might have been expected
to be positive if contamination had occurred. None of these were
positive during any of the testing.
Examination of the frequency histogram of the S/CO results (Fig.
1) demonstrates a clear separation of the
true-positive and -negative results. Expansion of the gray zone to S/CO
ratios of 0.8 to 2.0 would allow for the detection of low-level
false-positive results without significantly increasing the number of
repeat tests. Analysis of receiver operating characteristic curves
(Fig. 2) by utilizing the manufacturer's
equivalent zone and the expanded equivalent zone suggests that a wider
gray zone could decrease the number of false-positive reports and
improve the sensitivity and specificity of the assay.

View larger version (12K):
[in this window]
[in a new window]
|
FIG. 1.
Frequency distribution of S/CO ratios. ,
false-positive S/CO ratio; , manufacturer's equivocal zone.
|
|

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
Receiver operating characteristic curves. Symbols: ,
manufacturer's equivocal zone; , proposed equivocal zone.
|
|
The positive predictive value of the LCx assay in our population, with
a prevalence of 8.4%, was 91.7%. In a low-prevalence population, the
positive predictive value would decrease. In this setting, expansion of
the gray zone could be an important step in improving the predictive
value of positive results by decreasing the number of false-positive results.
Of some concern is the low sensitivity of the "gold standard"
traditional culture method. The bedside plating and immediate incubation employed during this study certainly allowed for optimum recovery, and yet the resolved sensitivity was only 77.1%. These findings are consistent with the 84% reported by Ching et al. (4) and the 50% reported by Buimer et al. (3)
and support the suggestion by Ching et al. (4) that N. gonorrhoeae infection in females is significantly underdiagnosed.
In this study, the LCx assay had a resolved sensitivity of 94.3%. This
is similar to that reported by Ching et al. and Buimer et al. (3,
4). Although the sample number was small, these data suggest that
the LCx assay is a statistically significantly more sensitive test
(McNemar test, P = 0.0265) than culture for detection
of N. gonorrhoeae in female endocervical specimens.
 |
ACKNOWLEDGMENT |
This study was supported in part by Abbott Laboratories, Inc.,
Abbott Park, Ill.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Pathology, Medical College of Wisconsin, 865 N. 87th St., P.O. Box
26509, Milwaukee, WI 53226-0509. Phone: (414) 257-6192. Fax: (414)
257-7899. E-mail: kskehl{at}post.its.mcw.edu.
 |
REFERENCES |
| 1.
| Abbott Laboratories. Personal communication.
|
| 1a.
|
Beam, C. A.
1992.
Strategies for improving power in diagnostic research.
Am. J. Radiol.
159:631-637.
[Abstract/Free Full Text] |
| 2.
|
Birkenmeyer, L.,
F. Blog, and A. S. Armstrong.
1992.
Preliminary evaluation of the ligase chain reaction for specific detection of Neisseria gonorrhoeae.
J. Clin. Microbiol.
30:3089-3094[Abstract/Free Full Text].
|
| 3.
|
Buimer, M.,
G. J. J. van Doornum,
S. Ching,
P. G. Peerbooms,
P. K. Plier,
D. Ram, and H. H. Lee.
1996.
Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by ligase chain reaction-based assays with clinical specimens from various sites: implication for diagnostic testing and screening.
J. Clin. Microbiol.
34:2395-2400[Abstract].
|
| 4.
|
Ching, S.,
H. H. Lee,
E. W. Hook,
M. R. Jacobs, and J. Zenilman.
1995.
Ligase chain reaction for detection of Neisseria gonorrhoeae in urogenital swabs.
J. Clin. Microbiol.
33:3111-3114[Abstract].
|
| 5.
|
Donders, G. G.,
V. van Gerven,
H. G. de Wet,
A. M. van Straten, and F. de Boer.
1996.
Rapid antigen tests for Neisseria gonorrhoeae and Chlamydia trachomatis are not accurate for screening women with disturbed vaginal lactobacillary flora.
Scand. J. Infect. Dis.
28:559-562[Medline].
|
| 6.
|
Hale, Y. M.,
M. E. Melton,
J. S. Lewis, and D. E. Willis.
1993.
Evaluation of the PACE 2 Neisseria gonorrhoeae assay by three public health laboratories.
J. Clin. Microbiol.
31:451-453[Abstract/Free Full Text].
|
| 7.
|
Iwen, P. C.,
R. A. Walker,
K. L. Warren,
D. M. Kelly,
S. H. Hinrichs, and J. Linder.
1996.
Evaluation of nucleic acid-based test (PACE 2C) for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens.
J. Clin. Microbiol.
33:2587-2591[Abstract].
|
| 7a.
|
Kehl, S.,
K. Georgakas,
G. Sedmak,
S. Gradus,
A. Singh, and S. Foldy.
1998.
Comparison of Abbott LCx ligase chain reaction with culture for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens, abstr. C-53, p. 140.
In
Abstracts of the 98th General Meeting of the American Society for Microbiology 1998. American Society for Microbiology, Washington, D.C.
|
| 8.
|
National Committee for Clinical Laboratory Standards.
1992.
Assessment of the clinical accuracy of laboratory tests using receiver operating characteristic (ROC) plots; approved guideline.
National Committee for Clinical Laboratory Standards, Villanova, Pa.
|
| 9.
|
National Committee for Clinical Laboratory Standards.
1996.
Quality assurance for commercially prepared microbiological culture media second edition; approved standard. NCCLS document M22-A2.
National Committee for Clinical Laboratory Standards, Wayne, Pa.
|
| 10.
|
Stary, A.,
B. Kopp,
B. Zahel,
S. Nerad,
L. Teodorowicz, and I. Horting-Muller.
1993.
Comparison of DNA-probe test and culture for the detection of Neisseria gonorrhoeae in genital samples.
Sex. Transm. Dis.
20:243-247[Medline].
|
| 11.
|
Thomas, E.,
S. D. Scott,
I. Grefkees,
G. Hession,
R. Pollock,
T. Martin, and W. Alvritton.
1986.
Validity and cost-effectiveness of the Gonozyme test in the diagnosis of gonorrhea.
Can. Med. Assoc. J.
134:121-124[Abstract].
|
| 12.
|
Thomason, J. L.,
S. M. Gelbart,
V. J. Sobieski,
R. J. Anderson,
M. B. Schulien, and P. R. Hamilton.
1989.
Effectiveness of Gonozyme for detection of gonorrhea in low-risk pregnant and gynecologic populations.
Sex. Transm. Dis.
16:28-31[Medline].
|
| 13.
|
Valspolder, F.,
J. A. Mutsaers,
F. Blog, and A. Notowicz.
1993.
Value of a DNA probe assay (Gen-Probe) compared with that of culture for diagnosis of gonococcal infection.
J. Clin. Microbiol.
31:107-110[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, December 1998, p. 3549-3551, Vol. 36, No. 12
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Whiley, D. M., Tapsall, J. W., Sloots, T. P.
(2006). Nucleic Acid Amplification Testing for Neisseria gonorrhoeae: An Ongoing Challenge. J. Mol. Diagn.
8: 3-15
[Abstract]
[Full Text]
-
Geraats-Peters, C. W. M., Brouwers, M., Schneeberger, P. M., van der Zanden, A. G. M., Bruisten, S. M., Weers-Pothoff, G., Boel, C. H. E., van den Brule, A. J. C., Harmsen, H. G., Hermans, M. H. A.
(2005). Specific and Sensitive Detection of Neisseria gonorrhoeae in Clinical Specimens by Real-Time PCR. J. Clin. Microbiol.
43: 5653-5659
[Abstract]
[Full Text]
-
Boyadzhyan, B., Yashina, T., Yatabe, J. H., Patnaik, M., Hill, C. S.
(2004). Comparison of the APTIMA CT and GC Assays with the APTIMA Combo 2 Assay, the Abbott LCx Assay, and Direct Fluorescent-Antibody and Culture Assays for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol.
42: 3089-3093
[Abstract]
[Full Text]
-
Cosentino, L. A., Landers, D. V., Hillier, S. L.
(2003). Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by Strand Displacement Amplification and Relevance of the Amplification Control for Use with Vaginal Swab Specimens. J. Clin. Microbiol.
41: 3592-3596
[Abstract]
[Full Text]
-
Diemert, D. J., Libman, M. D., Lebel, P.
(2002). Confirmation by 16S rRNA PCR of the COBAS AMPLICOR CT/NG Test for Diagnosis of Neisseria gonorrhoeae Infection in a Low-Prevalence Population. J. Clin. Microbiol.
40: 4056-4059
[Abstract]
[Full Text]
-
Chaudhry, U, Saluja, D
(2002). Detection of Neisseria gonorrhoeae by PCR using orf1 gene as target. Sex. Transm. Infect.
78: 72-72
[Full Text]
-
Van Der Pol, B., Martin, D. H., Schachter, J., Quinn, T. C., Gaydos, C. A., Jones, R. B., Crotchfelt, K., Moncada, J., Jungkind, D., Turner, B., Peyton, C., Kelly, J. F., Weiss, J. B., Rosenstraus, M.
(2001). Enhancing the Specificity of the COBAS AMPLICOR CT/NG Test for Neisseria gonorrhoeae by Retesting Specimens with Equivocal Results. J. Clin. Microbiol.
39: 3092-3098
[Abstract]
[Full Text]
-
Van Dyck, E., Smet, H., Van Damme, L., Laga, M.
(2001). Evaluation of the Roche Neisseria gonorrhoeae 16S rRNA PCR for Confirmation of AMPLICOR PCR-Positive Samples and Comparison of Its Diagnostic Performance According to Storage Conditions and Preparation of Endocervical Specimens. J. Clin. Microbiol.
39: 2280-2282
[Abstract]
[Full Text]
-
Van Dyck, E., Ieven, M., Pattyn, S., Van Damme, L., Laga, M.
(2001). Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by Enzyme Immunoassay, Culture, and Three Nucleic Acid Amplification Tests. J. Clin. Microbiol.
39: 1751-1756
[Abstract]
[Full Text]
-
Johnson, S. J., Green, D. H., Reed, D. A., Wood, L. S.
(2001). Semiautomation of Nucleic Acid-based Assays for Chlamydia trachomatis and Neisseria gonorrhoeae,. Clin. Chem.
47: 760-763
[Full Text]
-
Martin, D. H., Cammarata, C., Van Der Pol, B., Jones, R. B., Quinn, T. C., Gaydos, C. A., Crotchfelt, K., Schachter, J., Moncada, J., Jungkind, D., Turner, B., Peyton, C.
(2000). Multicenter Evaluation of AMPLICOR and Automated COBAS AMPLICOR CT/NG Tests for Neisseria gonorrhoeae. J. Clin. Microbiol.
38: 3544-3549
[Abstract]
[Full Text]
-
Gronowski, A. M., Copper, S., Baorto, D., Murray, P. R.
(2000). Reproducibility Problems with the Abbott Laboratories LCx Assay for Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol.
38: 2416-2418
[Abstract]
[Full Text]